Circulatory system devices panel
This article was originally published in The Gray Sheet
Executive Summary
Public meeting will be held April 12-14 in Washington, D.C. The panel will discuss premarket applications for implantable cardioverter defibrillators, prosthetic cardiac valves and interventional cardiology devices. Lilly's Cardiac Pacemakers, Inc. subsidiary says that its Endotak transvenous cardioverter defibrillator lead system is scheduled to be reviewed at the meeting. For further information contact Wolf Sapirstein at 301/427-1205.